SC

Sharda Cropchem Ltd

Q2 FY26Fertilizers & Agrochemicals

Sharda Cropchem Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹725
Market cap₹6.5K Cr
P/E10.5
Updated16 Oct 2026
Read4 min read

The short version

The company expects to cross INR5,000 crores in revenue for the current year, with a possibility of reaching INR5,200 crores (Page 17). For FY '26, Sharda Cropchem aims to maintain healthy EBITDA margins in the range of 15% to 18%.

From Sharda Cropchem Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • The company expects to cross INR5,000 crores in revenue for the current year, with a possibility of reaching INR5,200 crores (Page 17).
  • Regarding longer-term growth, the management is cautious and does not speculate, but acknowledges that reaching INR10,000 crores in 4 to 5 years could happen, though it cannot be reasonably predicted due to economic and market uncertainties (Page 17).
  • Volume growth for Q2 was strong at 36% year-on-year, contributing significantly to revenue growth (Page 15).
  • The second half of the fiscal year is expected to be stronger than the first half due to seasonal factors, particularly the spring agricultural season (Pages 14, 7).

2 more points from Sharda Cropchem Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Planned capex for FY '26 is INR 450 crores to INR 500 crores.
  • The investment focuses on increasing product registrations and strengthening the registration pipeline.
  • Capex till H1 FY '26 stood at INR 250 crores.
  • Strategy is backed by a strong pipeline reflecting resilience and growth focus.
  • Emphasis on expanding intangible assets such as registrations, which are complex and time-consuming but provide competitive advantage.

2 more points from Sharda Cropchem Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention the current or expected order book or pending orders for Sharda Cropchem Limited. However, relevant points related to orders and registrations include: - As of September 30, 2025, the company has 2,994 product registrations globally, with 1,068 registration applications pending approval. - The non-agrochemical business is made-to-order, with no stock held; every order is customized per customer requirements.

2 more points from Sharda Cropchem Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Sharda Cropchem Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sharda Cropchem Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sharda Cropchem Ltd Q2 FY26 results?

The company expects to cross INR5,000 crores in revenue for the current year, with a possibility of reaching INR5,200 crores (Page 17). For FY '26, Sharda Cropchem aims to maintain healthy EBITDA margins in the range of 15% to 18%.

What is Sharda Cropchem Ltd share price analysis?

Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 10.4 with a market cap of ₹6,545 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sharda Cropchem Ltd planning capital expenditure?

Planned capex for FY '26 is INR 450 crores to INR 500 crores.

Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.